Menu
Washingtoner
  • Home
  • Health
  • Artificial Intelligence
  • Technology
  • Entertainment
  • Software
  • Real Estate
  • Business
  • Education
Washingtoner

IntellaTriage Launches New Patient Engagement Service
Washingtoner/10280210

Trending...
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
  • Spokane: Drugs and Guns Seized in a Counter Narcotics Investigation
IntellaTriage
IntellaTriage, the nation's leading provider of after-hours nurse-first triage solutions, has launched a new complementary service line that will further enhance the post-acute patient experience through increased touchpoints, direct outreach, and real-time action plans.

BRENTWOOD, Tenn. - Washingtoner -- IntellaTriage, the nation's leading provider of after-hours nurse-first triage solutions, has introduced a new service designed to further elevate the patient experience for hospice and home health providers. This innovative offering will provide post-admission check-ins, visit utilization mapping, end-of-life education, and more, creating additional touchpoints for patients and their families.

The recently launched patient engagement service utilizes a comprehensive approach to connecting with patients and their families beyond routine home visits. By working with providers to tailor care plans to individual needs and offering consistent nurse support, the service fosters stronger patient relationships and deeper insight into patient status. These frequent touchpoints aim to improve key quality measures across the hospice and home health continuums. Hospice providers can expect to see widespread benefits of the service from reduced live discharges to increased visits in the last seven days of life, among other critical measures directly impacting patient experience.  Home health agencies will benefit from similarly aligned quality measures such as reduced rehospitalizations and improved patient outcome measures.

More on Washingtoner
  • Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
  • Kindering's 21st Luncheon Raises $220,000+ to Support Children with Disabilities and Their Families
  • Philadelphia-Area Entrepreneur Nouho M Kanneh Builds $37 Million Net Worth Across Real Estate, E-Commerce and Retail

As with all IntellaTriage services, the foundation of the patient engagement service lies in its highly trained nursing staff. IntellaTriage employs over 300 licensed nurses, all with post-acute bedside experience. These nurses undergo robust internal training programs that prepare them for remote phone support, equipping the company with a uniquely skilled team to deliver this new service effectively. The new service line also aligns with ongoing and recent Centers for Medicare & Medicaid Services (CMS) quality care initiatives that focus on outcomes and overall care coordination, such as the home health value-based payment model and the upcoming HOPE Assessment tool for hospice.

Daniel Reese, CEO of IntellaTriage, emphasized the significance of this new offering, stating, "We have been conducting tuck-in calls for our clients for years with excellent results which led us to explore a more formalized approach to patient engagement. We have found that nothing replaces direct outreach from a real nurse in real-time when it comes to actually moving the needle on patient outcomes. Our dedicated team of nurses has the expertise and resources to deliver the compassionate care needed without adding to the workload of an already stretched clinical workforce in the field. This service represents a rare alignment of improved patient care and enhanced financial performance for our partners, and we're excited to help them improve engagement across the care continuum and usher in a new era of quality care."

More on Washingtoner
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • The World's No.1 Superstar® Brings Christmas Back in Grand Style with Music, Cinematic Glamour, and Luxury Fashion
  • New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)
  • Christmas Beats Summer in Paris: Travel Photoshoots Peak on Dec. 30
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board

The service officially launched in January 2025, further solidifying IntellaTriage's commitment to improving both patient outcomes and operational efficiencies for post-acute providers across the country.

About IntellaTriage
Founded in 2008, IntellaTriage provides 24/7 nurse-first triage care to providers and their patients across the United States. Leveraging the largest network of remote licensed nurses in the post-acute care sector, the company delivers exceptional care when patients need it most, alleviating the burden on frontline clinicians and significantly reducing nurse burnout and turnover.

As the nursing shortage intensifies, IntellaTriage offers a critical solution by shielding nurses from the additional demands of on-call duties. In a healthcare landscape increasingly focused on quality care and the importance of patient outcomes, IntellaTriage is poised for continued growth, ensuring better patient experience while supporting care teams nationwide.

For more information, visit intellatriage.com.

Contact
Bernadette Smith
***@intellatriage.com


Source: IntellaTriage
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Spokane: City and County Issue Joint Housing and Homelessness Funding RFP
  • Spokane: Council Approves Additional Funding to Prepare for Inclement Weather
  • Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
  • ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
  • PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
  • Spokane: City And County Seek Federal Grant to Plan for Road Network Wildfire Resilience
  • The Great Junk Hunt Returns to Monroe: Kick Off Your Holiday Shopping at the Ultimate Vintage Treas
  • AI Trading Agents Track Aerospace and Defense US Stocks Amid Rising Technology Investment (SATS, GILT, TSAT, IREN, JOBY, LUNR)
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Evluma's RoadMax Edge Roadway Luminaires Earn DarkSky Approved Status
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • Tacoma: Public Hearing for Off-Street Parking Code Update Set for December 1
  • Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
  • Spokane: SPD Makes an Arrest in Yesterday's Early Morning Shooting
_catLbl0 _catLbl1

Popular on Washingtoner

  • Pre-Seed VC Martin Tobias Makes Fundraising Tool Available to Every Startup CEO as Investor Match - 262
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX) - 228
  • Final Week to Register for Free Spokane Community Conference - 208
  • Author Robert A. Robinson Introduces Anarchy at the AYP: - 143
  • LocalsVoted Launches: Local Rankings From Phone-Verified Votes, Not Paid Placement - 137
  • Simpalm Staffing Launches Tax Preparer Staffing for U.S. CPA Firms - 116
  • Meta Partnership Expanding as Omni One Orders Surge 3X -New Consumer Bundles, Defense Opportunities & AI Robotics: Virtuix Holdings: N A S D A Q: VTIX - 112
  • Self-Published Dad's Santa Book Finally Found After 3 Years on Amazon
  • Sycamore Dove Releases "Loving Every Moment"
  • FloorLine Launches Live Shop Floor Tracking for Small Manufacturers

Similar on Washingtoner

  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Haven Treatment Center Pays It Forward with Donation of 150 Food Boxes and Gift Cards to Evergreen
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute